-
2
-
-
0033771951
-
-
H. Olson G. Betton D. Robinson K. Thomas A. Monro G. Kolaja P. Lilly J. Sanders G. Sipes W. Bracken M. Dorato K. Van Deun P. Smith B. Berger A. Heller Regul. Toxicol. Pharmacol. 2000 32 56 67
-
(2000)
Regul. Toxicol. Pharmacol.
, vol.32
, pp. 56-67
-
-
Olson, H.1
Betton, G.2
Robinson, D.3
Thomas, K.4
Monro, A.5
Kolaja, G.6
Lilly, P.7
Sanders, J.8
Sipes, G.9
Bracken, W.10
Dorato, M.11
Van Deun, K.12
Smith, P.13
Berger, B.14
Heller, A.15
-
4
-
-
49849094738
-
-
J. D. Hughes J. Blagg D. A. Price S. Bailey G. A. DeCrescenzo R. V. Devraj E. Ellsworth Y. M. Fobian M. E. Gibbs R. W. Gilles N. Greene E. Huang T. Krieger-Burke J. Loesel T. Wager L. Whiteley Y. Zhang Bioorg. Med. Chem. Lett. 2008 18 4872 4875
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 4872-4875
-
-
Hughes, J.D.1
Blagg, J.2
Price, D.A.3
Bailey, S.4
Decrescenzo, G.A.5
Devraj, R.V.6
Ellsworth, E.7
Fobian, Y.M.8
Gibbs, M.E.9
Gilles, R.W.10
Greene, N.11
Huang, E.12
Krieger-Burke, T.13
Loesel, J.14
Wager, T.15
Whiteley, L.16
Zhang, Y.17
-
6
-
-
77950635141
-
-
Paper read before the Royal Society Of Edinburgh
-
A. Crum-Brown and T. R. Fraser, On the connection between chemical constitution and physiological action; with special reference to the physiological action of the salts of the ammonium bases derived from strychnia, brucia, the beta, code, morphia, and nicotine. Paper read before the Royal Society Of Edinburgh, 1868
-
(1868)
On the Connection between Chemical Constitution and Physiological Action; with Special Reference to the Physiological Action of the Salts of the Ammonium Bases Derived from Strychnia, Brucia, the Beta, Code, Morphia, and Nicotine.
-
-
Crum-Brown, A.1
Fraser, T.R.2
-
7
-
-
80052601462
-
-
T. Luker L. Alcaraz K. K. Chohan N. Blomberg D. S. Brown R. J. Butlin T. Elebring A. M. Griffin S. Guile S. St-Gallay B. Swahn S. Swallow M. J. Waring M. C. Wenlock P. D. Leeson Bioorg. Med. Chem. Lett. 2011 21 5673 5679
-
(2011)
Bioorg. Med. Chem. Lett.
, vol.21
, pp. 5673-5679
-
-
Luker, T.1
Alcaraz, L.2
Chohan, K.K.3
Blomberg, N.4
Brown, D.S.5
Butlin, R.J.6
Elebring, T.7
Griffin, A.M.8
Guile, S.9
St-Gallay, S.10
Swahn, B.11
Swallow, S.12
Waring, M.J.13
Wenlock, M.C.14
Leeson, P.D.15
-
8
-
-
35248817286
-
-
K. Azzaoui J. Hamon B. Faller S. Whitebread E. Jacoby A. Bender J. L. Jenkins L. Urban ChemMedChem 2007 2 874 880
-
(2007)
ChemMedChem
, vol.2
, pp. 874-880
-
-
Azzaoui, K.1
Hamon, J.2
Faller, B.3
Whitebread, S.4
Jacoby, E.5
Bender, A.6
Jenkins, J.L.7
Urban, L.8
-
13
-
-
84894883459
-
-
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm? fuseaction=Search.Overview&DrugName=THALOMID&CFID=8218219&CFTOKEN= e451e24190f95700-16389557-D7B7-C048-B991EF4E04171C49
-
-
-
-
15
-
-
68749083601
-
-
J. P. Valentin R. Bialecki L. Ewart T. Hammond D. Leishmann S. Lindgren V. Martinez C. Pollard W. Redfern R. Wallis J. Pharmacol. Toxicol. Methods 2009 60 152 158
-
(2009)
J. Pharmacol. Toxicol. Methods
, vol.60
, pp. 152-158
-
-
Valentin, J.P.1
Bialecki, R.2
Ewart, L.3
Hammond, T.4
Leishmann, D.5
Lindgren, S.6
Martinez, V.7
Pollard, C.8
Redfern, W.9
Wallis, R.10
-
18
-
-
84884590180
-
Big pharma screening collections: More of the same or unique libraries?
-
The AstraZeneca-Bayer Pharma AG case, 10.1016/j.drudis.2012.10.011, in press
-
T. Kogej, N. Blomberg, P. J. Greasley, S. Mundt, M. J. Vainio, J. Schamberger, G. Schmidt and J. Hüser, Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case, Drug Discovery Today 10.1016/j.drudis.2012.10.011, in press
-
Drug Discovery Today
-
-
Kogej, T.1
Blomberg, N.2
Greasley, P.J.3
Mundt, S.4
Vainio, M.J.5
Schamberger, J.6
Schmidt, G.7
Hüser, J.8
-
21
-
-
84894892678
-
-
https://www.ebi.ac.uk/chembl/
-
-
-
-
22
-
-
84862192766
-
-
A. Gaulton L. J. Bellis A. P. Bento J. Chambers M. Davies A. Hersey Y. Light S. McGlinchey D. Michalovich B. Al-Lazikani J. P. Overington Nucleic Acids Res. 2012 40 D1100 D1107
-
(2012)
Nucleic Acids Res.
, vol.40
-
-
Gaulton, A.1
Bellis, L.J.2
Bento, A.P.3
Chambers, J.4
Davies, M.5
Hersey, A.6
Light, Y.7
McGlinchey, S.8
Michalovich, D.9
Al-Lazikani, B.10
Overington, J.P.11
-
25
-
-
81855199785
-
-
F. Nigsch E. Lounkine P. McCarren B. Cornett M. Glick K. Azzaoui L. Urban P. Marc A. Mueller F. Hahne D. J. Heard J. L. Jenkins Expert Opin. Drug Metab. Toxicol. 2011 7 1497 1511
-
(2011)
Expert Opin. Drug Metab. Toxicol.
, vol.7
, pp. 1497-1511
-
-
Nigsch, F.1
Lounkine, E.2
McCarren, P.3
Cornett, B.4
Glick, M.5
Azzaoui, K.6
Urban, L.7
Marc, P.8
Mueller, A.9
Hahne, F.10
Heard, D.J.11
Jenkins, J.L.12
-
27
-
-
33845479693
-
-
B. Faller J. Wang A. Zimmerlin L. Bell J. Hamon S. Whitebread K. Azzaoui D. Bojanic L. Urban Expert Opin. Drug Metab. Toxicol. 2006 2 823 833
-
(2006)
Expert Opin. Drug Metab. Toxicol.
, vol.2
, pp. 823-833
-
-
Faller, B.1
Wang, J.2
Zimmerlin, A.3
Bell, L.4
Hamon, J.5
Whitebread, S.6
Azzaoui, K.7
Bojanic, D.8
Urban, L.9
-
30
-
-
84859269944
-
-
J. Peters J. Hert C. Bissantz A. Hillebrecht G. Gerebtzoff S. Bendels F. Tillier J. Migeon H. Fischer W. Guba M. Kansy Drug Discovery Today 2012 17 7-8 325 335
-
(2012)
Drug Discovery Today
, vol.17
, Issue.78
, pp. 325-335
-
-
Peters, J.1
Hert, J.2
Bissantz, C.3
Hillebrecht, A.4
Gerebtzoff, G.5
Bendels, S.6
Tillier, F.7
Migeon, J.8
Fischer, H.9
Guba, W.10
Kansy, M.11
-
36
-
-
84858976293
-
-
K. Briggs M. Cases D. J. Heard M. Pastor F. Pognan F. Sanz C. H. Schwab T. Steger-Hartmann A. Sutter D. K. Watson J. D. Wichard Int. J. Mol. Sci. 2012 13 3820 3846
-
(2012)
Int. J. Mol. Sci.
, vol.13
, pp. 3820-3846
-
-
Briggs, K.1
Cases, M.2
Heard, D.J.3
Pastor, M.4
Pognan, F.5
Sanz, F.6
Schwab, C.H.7
Steger-Hartmann, T.8
Sutter, A.9
Watson, D.K.10
Wichard, J.D.11
|